Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MIC:GEMA's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.485 * Ranked among companies with meaningful Equity-to-Asset only.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Equity-to-Asset Related Terms
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Equity-to-Asset Chart
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Equity-to-Asset vs Healthcare Providers & Services Industry
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a Equity-to-Asset of 0.35 as of Dec. 2023. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Equity-to-Asset too high?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Equity-to-Asset is 0.35. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's value of 0.35 is 27.8% below this industry median. Overall, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Equity-to-Asset compare to FICO and SPSC?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Equity-to-Asset of 0.35 can be compared against companies in the Healthcare Providers & Services industry. The industry median Equity-to-Asset is 0.49. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's value of 0.35 is 27.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Equity-to-Asset of 0.35 is 27.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Equity-to-Asset is 0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC stock overvalued right now?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a current Equity-to-Asset of 0.35. The current Equity-to-Asset is 0.35 and 27.8% below the Healthcare Providers & Services industry median of 0.49. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA), the current Equity-to-Asset is 0.35 as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation, and Umbilical Cord tissue, among others.
17GF Score
Get the complete analysis for MIC:GEMA
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIC:GEMA has been successfully added to your 
